OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients

Source: Nasdaq GlobeNewswire / 30 Aug 2021 16:17:19   America/New_York